medigraphic.com

2007, Number 6

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2007; 45 (6)

Knowledge, Experience and Behavior at Climacteric and Menopause Stages Among Family Medicine Female Users at IMSS

Velasco-Murillo V, Fernández-Gárate IH, Ojeda-Mijares RI, Padilla-Vallejo I, Cruz-Mejía L

Language: Spanish
References: 20
Page: 549-556
PDF size: 139.12 Kb.


ABSTRACT

Objective: to identify knowledge, experiences and behaviors of climacteric and menopause women users of family medicine services of Instituto Mexicano del Seguro Social (IMSS).
Methods: a descriptive study that included a 37 questions survey about climacteric and menopause was conducted in a national representative sample of 4162 women aged 45 to 59 years between September 2004 and January 2005. The analysis was made by using descriptive statistics and χ2.
Results: 82.9% of women knew about menopause or its significance; 82.1% identified hot flushes as a climacteric symptom; 46.1% knew about pharmacologic treatment and 25.6% knew about postmenopausal complications such as osteoporosis. Only 26.6% mentioned preventive measures as physical exercise or consumption food with high calcium content. Their main information sources were media communication. Mean age at menopause was 46.8 years old; 57.7% had symptoms at interview and 18.4% were taking pharmacologic treatment, mainly (53.3%) hormones. 11.1% of treated women had had side effects. 10.7% had received pharmacologic treatment and 39.4% had withdraw either by medical indication or by side effects (23 %).
Conclusions: knowledge about climacteric was scarce and obtained from non-medical sources; use of pharmacological treatment and preventive behavior was low. We recommended reinforcing the information and education about treatment and favorable life styles by health personal.


REFERENCES

  1. Velasco-Murillo V, Cardona-Pérez JA, Navarrete-Hernández E, Madrazo-Navarro M. Atención del climaterio y prevención de las complicaciones de la menopausia en medicina familiar. Rev Med IMSS 1998;36(6):463-476.

  2. Xu J, Bartoces M, Neale AV, Dailey RK, Northrup J, Schwartz KL. Natural history of menopause symptoms in primary care patients: A MetroNet study. J Am Board Fam Pract 2005;18(5):374-382.

  3. Kelsey JL, Prill MM, Keegan TH, Quesenberry CP Jr, Sydney S. Risk factors for pelvis fracture in older persons. Am J Epidemiol 2005;62(9):879-886.

  4. Barentsen R. The climacteric in the Netherlands: a review of Dutch studies on epidemiology, attitudes and use of hormone replacement therapy. Eur J Obstet Gynecol Reprod Biol 1996;64 Suppl:S7-S11.

  5. Melby MK, Lock M, Kaufert P. Culture and symptoms reporting at menopause. Hum Reprod Update 2005;11(5):495-512.

  6. Velasco-Murillo V, Navarrete-Hernández E, Ojeda- Mijares RI, Pozos-Cavanzo JL, Camacho-Rodríguez MA, Cardona-Pérez JA. Experiencias y conocimientos sobre climaterio y menopausia en mujeres de la ciudad de México. Gac Med Mex 2000;136(6)555-564.

  7. Instituto Mexicano del Seguro Social, Dirección de Prestaciones Médicas. Encuesta Nacional de Coberturas 2003. México: Programas Integrados de Salud. Síntesis; 2003.

  8. McVeigh C. Perimenopause: more than hot flushes and night sweats for some Australian women. J Obstet Gynecol Neonatal Nurs 2005;34(1):21-27.

  9. Oddens BJ, Boulet MJ. Hormone replacement therapy among Danish women 45-65 years: prevalence, determinants, and compliance. Obstet Gynecol 1997;90(2):269-277.

  10. Utian WH, Bogas PP. The North American Menopause Society 1998: Survey postmenopausal women’s perceptions about menopause and midlife. Menopause 1999;6(2):122-128.

  11. Sulak PJ. The perimenopause: a critical time in woman’s life. Int J Fertil Menopausal Stud 1996;41(2):85-89.

  12. Velasco-Murillo V, Navarrete-Hernández E, Pozos-Cavanzo JL, Ojeda-Mijares RI, Camacho-Rodríguez MA. Fracturas en mujeres posmenopáusicas en el IMSS: frecuencia y costos de su atención hospitalaria. Gac Med Mex 2003; 139(5):453-458.

  13. Wiktorowicz ME, Goeree R, Papaionnou A, Adachi JD, Papadimitropoulos E. Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int 2001;12(4):271-278.

  14. Riggs BL, Melton LJ 3rd. The world-wide problem of osteoporosis: insights afforded by epidemiology. Bone 1995;17(5 Suppl):S505-S511.

  15. Te Velde ER, Dorland M, Broekmans FJ. Age at menopause as a marker of reproductive ageing. Maturitas 1998;30(2):119-125.

  16. Wilbush J. Confrontation in the climacteric. JR Soc Med 1994;87(6):342-347.

  17. Genazzani AR, Schneider HP, Panay N, Nijland EA. The European Menopause Survey 2005: women’s perceptions on the menopause and postmenopausal hormona therapy. Gynecol Endocrinol 2006;22(7):369-375.

  18. McIntosh J, Blalock SJ. Effects of media coverage of Women’s Health Initiative study on attitudes and behavior of women receiving hormone replacement therapy. Am J Health Syst Pharm 2005; 62(1):69-74.

  19. Hillman JJ, Zuckerman IH, Lee E. The impact of the Women’s Health Initiative on hormone replacement therapy in a Medicaid program. J Womens Health 2004;13(9):986-992.

  20. Velasco-Murillo V. Tratamiento con estrógenos en el climaterio y la posmenopausia después de 2002 ¿Aún puede prescribirse? Rev Med Inst Mex Seguro Soc 2006;44(1):61-69.




2020     |     www.medigraphic.com